Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,000 shares at $17.03 ($17K) on 2023-02-14, disclosed to the SEC on 2023-02-15.
Scheduled sale ($17k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 441 | $7K | 44.1% |
| 2 | $17.01 | 42 | $714 | 4.2% |
| 3 | $17.02 | 417 | $7K | 41.7% |
| 4 | $17.03 | 100 | $2K | 10.0% |
| Total | $17.01 avg | 1,000 | $17K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |